These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21824185)

  • 1. Comparison of longitudinal point-of-care and high-performance liquid chromatography HbA1c measurements in a multi-centre trial.
    Alleyn CR; Laffel LM; Volkening LK; Anderson BJ; Nansel TR; Wysocki T; Weissberg-Benchell J
    Diabet Med; 2011 Dec; 28(12):1525-9. PubMed ID: 21824185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community.
    Martin DD; Shephard MD; Freeman H; Bulsara MK; Jones TW; Davis EA; Maguire GP
    Med J Aust; 2005 May; 182(10):524-7. PubMed ID: 15896181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agreement between HbA1c measured by DCA 2000 and by HPLC: effects of fetal hemoglobin concentrations.
    Diem P; Wälchli M; Mullis PE; Marti U
    Arch Med Res; 2004; 35(2):145-9. PubMed ID: 15010195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of structure, process, and policy on HbA(1c) levels in treatment of children and adolescents with type 1 diabetes.
    Hanberger L; Samuelsson U; Berterö C; Ludvigsson J
    Diabetes Res Clin Pract; 2012 Jun; 96(3):331-8. PubMed ID: 22326692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial.
    ; Wilson DM; Xing D; Beck RW; Block J; Bode B; Fox LA; Hirsch I; Kollman C; Laffel L; Ruedy KJ; Steffes M; Tamborlane WV
    Diabetes Care; 2011 Mar; 34(3):540-4. PubMed ID: 21266647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.
    Salardi S; Zucchini S; Santoni R; Ragni L; Gualandi S; Cicognani A; Cacciari E
    Diabetes Care; 2002 Oct; 25(10):1840-4. PubMed ID: 12351488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of IFCC-calibrated HbA(1c) from laboratory and point of care testing systems.
    Manley SE; Hikin LJ; Round RA; Manning PW; Luzio SD; Dunseath GJ; Nightingale PG; Stratton IM; Cramb R; Sikaris KA; Gough SC; Webber J
    Diabetes Res Clin Pract; 2014 Sep; 105(3):364-72. PubMed ID: 24985893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin Glycosylation Index is not related with blood glucose.
    Merino-Torres JF; Fajardo-Montañana C; Ferrer-García JC; Piñón-Sellés F
    J Diabetes Complications; 2003; 17(5):249-53. PubMed ID: 12954152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent individual tracking within overall improvement in HbA1c in a UK paediatric diabetes clinic over 15 years.
    Edge JA; James T; Shine B
    Diabet Med; 2010 Nov; 27(11):1284-8. PubMed ID: 20950387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between glycated haemoglobin levels and mean glucose levels over time.
    Nathan DM; Turgeon H; Regan S
    Diabetologia; 2007 Nov; 50(11):2239-44. PubMed ID: 17851648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of blood glucose and HbA(1c) goals on glycaemic control in children and adolescents with Type 1 diabetes.
    Boot M; Volkening LK; Butler DA; Laffel LM
    Diabet Med; 2013 Mar; 30(3):333-7. PubMed ID: 23190135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience.
    Bhowmik B; Diep LM; Munir SB; Rahman M; Wright E; Mahmood S; Afsana F; Ahmed T; Khan AK; Hussain A
    Diabet Med; 2013 Mar; 30(3):e70-7. PubMed ID: 23199158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control.
    Kilpatrick ES; Rigby AS; Atkin SL
    Clin Chem; 2007 May; 53(5):897-901. PubMed ID: 17384010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of 2 years of patient data to estimate intra-laboratory total imprecision of HbA(1c) measured by multiple HPLC analyzers.
    Tran DV; Cembrowski GS; Higgins TN
    Clin Biochem; 2008 Feb; 41(3):177-9. PubMed ID: 18047837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
    Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?
    Kuenen JC; Borg R; Kuik DJ; Zheng H; Schoenfeld D; Diamant M; Nathan DM; Heine RJ;
    Diabetes Care; 2011 Aug; 34(8):1843-7. PubMed ID: 21700921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the relative contribution of blood glucose levels at different time points of the day to HbA1c in Type 1 diabetes?
    Hillman N; Herranz L; Grande C; Vaquero PM; Pallardo LF
    Diabet Med; 2004 May; 21(5):468-70. PubMed ID: 15089792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials.
    DeFronzo RA; Stonehouse AH; Han J; Wintle ME
    Diabet Med; 2010 Mar; 27(3):309-17. PubMed ID: 20536494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study.
    Huppertz E; Pieper L; Klotsche J; Stridde E; Pittrow D; Böhler S; Lehnert H
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):6-14. PubMed ID: 18465681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.
    Aiello LP; Ayala AR; Antoszyk AN; Arnold-Bush B; Baker C; Bressler NM; Elman MJ; Glassman AR; Jampol LM; Melia M; Nielsen J; Wolpert HA;
    JAMA Ophthalmol; 2015 Aug; 133(8):888-96. PubMed ID: 25996273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.